Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study

被引：21
|
作者：
Wessels, Alette M. [1 ]
Bies, Robert R. [1 ,2 ]
Pollock, Bruce G. [2 ,3 ,4 ]
Schneider, Lon S. [5 ]
Lieberman, Jeffrey A. [6 ,9 ,10 ,11 ,12 ,13 ,14 ]
Stroup, Scott [6 ]
Li, Claire H. [1 ]
Coley, Kim [7 ]
Kirshner, Margaret M. [4 ]
Marder, Stephen R. [8 ,15 ,16 ,17 ,18 ,19 ,20 ]
机构：
[1] Indiana Univ Sch Med, Dept Med, Div Clin Pharmacol, Indianapolis, IN USA
[2] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[3] Univ Toronto, Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada
[4] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[5] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[6] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[7] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA
[8] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[9] GlaxoSmithKline, London, England
[10] Intracellular Therapies, New York, NY 10032 USA
[11] Eli Lilly & Co, Indianapolis, IN USA
[12] Pierre Fabre, Castres, France
[13] Psychogenics, Tarrytown, NY USA
[14] Wyeth, Madison, NJ USA
[15] Advisory Board Wyeth, Madison, NJ USA
[16] Otsuka, Tokyo, Japan
[17] Sanofi Aventis, Bombay, Maharashtra, India
[18] Lundbeck, Copenhagen, Denmark
[19] Pfizer, New York, NY USA
[20] Schering Plough Corp, Kenilworth, NJ 07033 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 11期
基金：
加拿大健康研究院;
关键词：
ziprasidone; population pharmacokinetics; schizophrenia; CLINICAL ANTIPSYCHOTIC TRIALS; PROJECT; IMPACT; DRUG; RACE;
D O I：
10.1177/0091270010387604
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1587 / 1591
页数：5
相关论文
共 50 条
  • [1] Use of population pharmacokinetic modeling to characterize intramuscular pharmacokinetics for ziprasidone in schizophrenic patients.
    Shad, MU
    Preskorn, SH
    Miceli, J
    Wilner, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 171 - 171
  • [2] Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking
    Jin, Yuyan
    Pollock, Bruce G.
    Coley, Kim
    Miller, Del
    Marder, Stephen R.
    Florian, Jeff
    Schneider, Lon
    Lieberman, Jeffrey
    Kirshner, Margaret
    Bies, Robert R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (01): : 73 - 80
  • [3] Population pharmacokinetic model of quetiapine using highly sparse data from the CATIE study
    Chew, ML
    Pollock, BG
    Coley, K
    Marder, SR
    Miller, D
    Bies, RR
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 74S - 74S
  • [4] Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study
    Feng, Yan
    Pollock, Bruce G.
    Coley, Kim
    Marder, Stephen
    Miller, Del
    Kirshner, Margaret
    Aravagiri, Manickam
    Schneider, Lon
    Bies, Robert R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 629 - 639
  • [5] Use of population pharmacokinetic modeling to characterize the intramuscular pharmacokinetics of the novel antipsychotic agent ziprasidone in schizophrenic patients
    Miceli, J
    Preskorn, S
    Wilner, K
    Folger, C
    Tensfeldt, T
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 289 - 290
  • [6] Genious study: The use of ziprasidone for the treatment of patients with schizophrenia
    Lyras, L.
    Tzavaras, N.
    Kaprinis, G.
    Karavatos, A.
    Mantonakis, I.
    Tzebelikos, E.
    EUROPEAN PSYCHIATRY, 2008, 23 : S128 - S129
  • [7] EFFECTIVENESS OF SWITCHING FROM ARIPIPRAZOLE TO ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA
    Yoon, Jin-Sang
    Kim, Sung-Wan
    Shin, I. S.
    Kim, J. M.
    Yoo, J. A.
    Bae, K. Y.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 327 - 327
  • [8] Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients With Schizophrenia
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Bae, Kyung-Yeol
    Yang, Su-Jin
    Yoon, Jin-Sang
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (03) : 121 - 125
  • [9] EFFECTIVENESS OF SWITCHING FROM ARIPIPRAZOLE TO ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Bae, Kyung-Yeol
    Yang, Su-Jin
    Yoon, Jin-Sang
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 379 - 379
  • [10] Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia
    Yoon, J. -S.
    Lee, J. -H.
    Kim, S. -W.
    Yang, S. -J.
    Jang, J. -E.
    Kim, J. -M.
    Shin, I. -S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 246 - 247
12345